Applied Therapeutics, Inc. (APLT)
NASDAQ: APLT · Real-Time Price · USD
0.5136
+0.0142 (2.84%)
Aug 21, 2025, 3:42 PM - Market open
Applied Therapeutics Market Cap
Applied Therapeutics has a market cap or net worth of $73.96 million as of August 21, 2025. Its market cap has decreased by -89.23% in one year.
Market Cap
73.96M
Enterprise Value
43.15M
1-Year Change
-89.23%
Ranking
Category
Stock Price
$0.51
Market Cap Chart
Since May 14, 2019, Applied Therapeutics's market cap has decreased from $160.29M to $73.96M, a decrease of -53.86%. That is a compound annual growth rate of -11.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 20, 2025 | 71.92M | -27.81% |
| Dec 31, 2024 | 99.62M | -61.49% |
| Dec 29, 2023 | 258.72M | 608.33% |
| Dec 30, 2022 | 36.52M | -84.43% |
| Dec 31, 2021 | 234.63M | -52.60% |
| Dec 31, 2020 | 494.96M | -2.00% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 14, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 631.30B |
| Johnson & Johnson | 428.20B |
| AbbVie | 364.25B |
| UnitedHealth Group | 275.54B |
| AstraZeneca | 246.71B |
| Novartis AG | 242.21B |
| Novo Nordisk | 241.79B |
| Abbott Laboratories | 228.44B |